Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

SLFN11 is Widely Expressed in Pediatric Sarcoma and Induces Variable Sensitization to Replicative Stress Caused By DNA-Damaging Agents.

Molecular cancer therapeutics | 2021

Pediatric sarcomas represent a heterogeneous group of malignancies that exhibit variable response to DNA-damaging chemotherapy. Schlafen family member 11 protein (SLFN11) increases sensitivity to replicative stress and has been implicated as a potential biomarker to predict sensitivity to DNA-damaging agents (DDA). SLFN11 expression was quantified in 220 children with solid tumors using IHC. Sensitivity to the PARP inhibitor talazoparib (TAL) and the topoisomerase I inhibitor irinotecan (IRN) was assessed in sarcoma cell lines, including SLFN11 knock-out (KO) and overexpression models, and a patient-derived orthotopic xenograft model (PDOX). SLFN11 was expressed in 69% of pediatric sarcoma sampled, including 90% and 100% of Ewing sarcoma and desmoplastic small round-cell tumors, respectively, although the magnitude of expression varied widely. In sarcoma cell lines, protein expression strongly correlated with response to TAL and IRN, with SLFN11 KO resulting in significant loss of sensitivity in vitro and in vivo Surprisingly, retrospective analysis of children with sarcoma found no association between SLFN11 levels and favorable outcome. Subsequently, high SLFN11 expression was confirmed in a PDOX model derived from a patient with recurrent Ewing sarcoma who failed to respond to treatment with TAL + IRN. Selective inhibition of BCL-xL increased sensitivity to TAL + IRN in SLFN11-positive resistant tumor cells. Although SLFN11 appears to drive sensitivity to replicative stress in pediatric sarcomas, its potential to act as a biomarker may be limited to certain tumor backgrounds or contexts. Impaired apoptotic response may be one mechanism of resistance to DDA-induced replicative stress.

Pubmed ID: 34413129 RIS Download

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Anti-DNA-RNA Hybrid [S9.6] Antibody (antibody)

RRID:AB_2687463

This monoclonal targets DNA-RNA Hybrid

View all literature mentions

alpha Tubulin Antibody (antibody)

RRID:AB_521686

This monoclonal targets alpha Tubulin

View all literature mentions

β-Actin (13E5) Rabbit mAb (antibody)

RRID:AB_2223172

This monoclonal targets beta-Actin

View all literature mentions

Bax Antibody (antibody)

RRID:AB_10695870

This polyclonal targets Bax

View all literature mentions

Bak (D4E4) Rabbit mAb (antibody)

RRID:AB_2716685

This monoclonal targets Bak

View all literature mentions

Anti-SLFN11 polyclonal antibody (antibody)

RRID:AB_1856613

This polyclonal targets SLFN11

View all literature mentions

EW-13 (cell line)

RRID:CVCL_1211

Cell line EW-13 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

U2OS (cell line)

RRID:CVCL_0042

Cell line U2OS is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

SJSA-1 (cell line)

RRID:CVCL_1697

Cell line SJSA-1 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

SaOS-2 (cell line)

RRID:CVCL_0548

Cell line SaOS-2 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

Rh30 (cell line)

RRID:CVCL_0041

Cell line Rh30 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

JN-DSRCT-1 (cell line)

RRID:CVCL_9W68

Cell line JN-DSRCT-1 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

EW-11 (cell line)

RRID:CVCL_1209

Cell line EW-11 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

EW-18 (cell line)

RRID:CVCL_1213

Cell line EW-18 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

CHLA-258 (cell line)

RRID:CVCL_A058

Cell line CHLA-258 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

SU-CCS-1 (cell line)

RRID:CVCL_B470

Cell line SU-CCS-1 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

Rh3 (cell line)

RRID:CVCL_L415

Cell line Rh3 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

143B (cell line)

RRID:CVCL_2270

Cell line 143B is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

H-EMC-SS (cell line)

RRID:CVCL_1238

Cell line H-EMC-SS is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

ES1 (cell line)

RRID:CVCL_1198

Cell line ES1 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

CADO-ES1 (cell line)

RRID:CVCL_1103

Cell line CADO-ES1 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

EW-8 (cell line)

RRID:CVCL_V618

Cell line EW-8 is a Cancer cell line with a species of origin Homo sapiens

View all literature mentions

A-673 clone Asp114 (cell line)

RRID:CVCL_JM58

Cell line A-673 clone Asp114 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

ES8 (cell line)

RRID:CVCL_1204

Cell line ES8 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions